Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons
1 other identifier
interventional
123
1 country
1
Brief Summary
The purpose of this trial is to study the safety, tolerability and efficacy of an almond enriched hypocaloric diet on weight loss and weight maintenance, as well as on established and emerging cardiovascular risk factors in approximately 112 overweight and obese persons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 obesity
Started Feb 2005
Longer than P75 for phase_1 obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 19, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedMarch 28, 2013
January 1, 2008
2.7 years
September 14, 2005
March 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the effects of an almond-enriched (2 oz/day) hypocaloric, low-fat diet on body weight and body composition in overweight and obese persons
6 months
Secondary Outcomes (1)
To evaluate the effects of the almond enriched diet on established and emerging surrogate markers of coronoary artery disease (CAD) risk
6 months
Study Arms (2)
1
EXPERIMENTALAlmond enriched diet
2
ACTIVE COMPARATORLow-fat diet
Interventions
Subjects will consume 2 oz. of almond per day in addition to a low-fat diet
Eligibility Criteria
You may qualify if:
- Body mass index (BMI) \> 27 but \<40
- years of age
- Men and non-pregnant or lactating women
- Subjects must be willing to comply with all study-related procedures
You may not qualify if:
- Uncontrolled hypertension
- Diabetes or use of anti-hyperglycemic medication
- Dyslipidemia requiring prescription drug therapy as defined by NCEP ATPIII guidelines at screening
- Known allergy or sensitivity to nuts
- Known atherosclerotic cardiovascular disease
- History of congestive heart failure
- History of a non-skin malignancy within the previous 5 years
- Any major active rheumatologic, pulmonary, hepatic, renal, dermatologic disease or inflammatory condition
- History of being HIV positive
- History of alcohol or drug abuse
- Weight-loss inducing medications or dietary supplements within 3 months prior to enrollment.
- Weight loss \> 5 kg during the last 6 months
- Participation in an investigational drug study within 6 weeks prior to screening
- Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Temple Universitylead
- Almond Board of Californiacollaborator
Study Sites (1)
Temple University
Philadelphia, Pennsylvania, 19140, United States
Related Publications (3)
Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Vidgen E, Lapsley KG, Trautwein EA, Parker TL, Josse RG, Leiter LA, Connelly PW. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism. 2003 Nov;52(11):1478-83. doi: 10.1016/s0026-0495(03)00260-9.
PMID: 14624410BACKGROUNDWien MA, Sabate JM, Ikle DN, Cole SE, Kandeel FR. Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord. 2003 Nov;27(11):1365-72. doi: 10.1038/sj.ijo.0802411.
PMID: 14574348BACKGROUNDFoster GD, Shantz KL, Vander Veur SS, Oliver TL, Lent MR, Virus A, Szapary PO, Rader DJ, Zemel BS, Gilden-Tsai A. A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesity. Am J Clin Nutr. 2012 Aug;96(2):249-54. doi: 10.3945/ajcn.112.037895. Epub 2012 Jun 27.
PMID: 22743313DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary D Foster, PhD
Temple University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 19, 2005
Study Start
February 1, 2005
Primary Completion
October 1, 2007
Study Completion
October 1, 2009
Last Updated
March 28, 2013
Record last verified: 2008-01